You just read:

Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn® in ALS

News provided by

BrainStorm Cell Therapeutics Inc.

Jul 21, 2017, 01:00 ET